Bringing Cure...Building Hope...
Home | Blog | Events

Oncology Drugs Approved For
Leukemia by US FDA

IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.

List of Drugs Approved for Leukemia Treatment

Leukemia Treatment is highly variable. For slow-growing leukaemias, treatment may include monitoring. For aggressive leukaemias, treatment includes chemotherapy that's sometimes followed by radiation and stem-cell transplant.

The following lists anti-cancer drugs, US FDA and Indian Generic brand approved by the Food and Drug Administration (FDA) for Leukemia treatment. The list includes generic and brand names are in some way related to, or used in the treatment of this condition. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

ATRIANCE

ATRIANCE (NELARABINE) 5 mg/ml solution for infusion.

More Details...
BESPONSA

BESPONSA (inotuzumab ozogamicin) for injection, for intravenous use. Initial U.S. Approval: 2017.

More Details...
BLINCYTO

BLINCYTO ® (blinatumomab) for injection, for intravenous use. Initial U.S. Approval: 2014

More Details...
BOSULIF

BOSULIF ® (bosutinib) tablets, for oral use. Initial U.S. Approval: XXXX.

More Details...
NERLYNX

NERLYNX (neratinib) tablets, for oral use Initial U.S. Approval: 2017

More Details...
NOLVADEX

NOLVADEX (Tamoxifen Citrate) tablets, for oral use

More Details...
ERWINAZE

ERWINAZE (asparaginase Erwinia chrysanthemi) for injection, intramuscular use Initial U.S. Approval: 2011

More Details...
VYXEOS

VYXEOS ® (daunorubicin and cytarabine) liposome for injection, for intravenous use. Initial U.S. Approval: 2017

More Details...
GLEEVEC

GLEEVEC (imatinib mesylate) tablets for oral use Initial U.S. Approval: 2001

More Details...
MabCampath

MabCampath 10 mg/ml concentrate for solution for infusion (ALEMTUZUMAB)

More Details...
ONCASPAR

ONCASPAR ® (pegaspargase) injection, for intramuscular or intravenous use Initial U.S. Approval: 1994

More Details...
SYNRIBO

SYNRIBO ™ (omacetaxine mepesuccinate) for Injection, for subcutaneous use Initial U.S. Approval: 2012

More Details...
TAXOTERE

TAXOTERE (docetaxel) Injection. Initial U.S. Approval: 1996

More Details...
ICLUSIG

ICLUSIG ® (ponatinib) tablets for oral use. Initial U.S. Approval: 2012

More Details...
TASIGNA

TASIGNA ® (nilotinib) Capsules. Initial U.S. Approval: 2007

More Details...
VENCLEXTA

VENCLEXTA ™ (venetoclax) tablets, for oral use. Initial U.S. Approval: 2016

More Details...
XOSPATA

XOSPATA ® (gilteritinib) tablets, for oral use. Initial U.S. Approval: 2018

More Details...
NEUPOGEN

NEUPOGEN ® (filgrastim) injection, for subcutaneous or intravenous useInitial U.S. Approval: 1991

More Details...
ONTRUZANT

ONTRUZANT (trastuzumab-dttb) for injection

More Details...
TARCEVA

TARCEVA ® (erlotinib) tablets, oral Initial U.S. Approval: 2004

More Details...
ZYDELIG

ZYDELIG ® (idelalisib) tablets, for oral use. Initial U.S. Approval: 2014

More Details...
Note:-

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

CONTACT DETAILS
IPN, New Delhi India
Mobile: +91-9891296838 / 9811747774
WhatsApp: +91-9891296838
Email: info@indianpharmanetwork.co.in
Social Media:

Indian Pharma Network is registered medical pharmacy for Oncology Products in India.Helps you to access FDA approved Leukemia medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Leukemia Medicines in China, UAE, Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

If you have a question relating to anti-cancer medicines approved for treatment of Leukemia, a problem which you do not know how to resolve it, or concrete inquiry - we are here for you. We will answer you via email urgent@indianpharmanetwork.co.in as soon as possible. If you prefer to be contacted by phone, please leave your phone number. Or text your message in WhatsApp Number +91 9891296838 / 9811747774.

Indian Pharma Network, New Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur

US FDA Approved Oncology Drugs

For Lymphoma

The list includes US FDA approved brand drugs names are in some way related to, or used in the treatment of this condition.

IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India.

US FDA Approved Oncology Drugs

For Multiple Myeloma

The list includes US FDA approved brand drugs names are in some way related to, or used in the treatment of this condition.

IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India.

Indian FDA Approved Oncology Drugs

For Melanoma

The list includes FDA approved brand drugs names are in some way related to, or used in the treatment of this condition.

IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India.

Indian Pharma Network (IPN), Delhi. India

IPN, Delhi is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India. IPN, New Delhi helps patient, providing solutions on how to get access of anti cancer medicines which is not available in India.

BRANCH OFFICE : NEW DELHI | BENGALURU | KOLKATA | LUCKNOW | JODHPUR

Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Saudi Arabia | South Africa

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016

Mobile / WhatsApp / Phone

M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support

info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in